97839-99-1

Basic information

• Product Name: 4-(4-CHLORO-PHENOXY)-PIPERIDINE
• Synonyms: CHEMBRDG-BB 4004477;ASINEX-REAG BAS 09615184;4-(4-CHLORO-PHENOXY)-PIPERIDINE;4-(4-Chloro-phnenoxy)-piperidine;4-(4-chlorophenoxy)piperidine(SALTDATA: HCl);4-(4-Chlorophenoxy)piperidine,98%
• CAS NO: 97839-99-1
• Molecular Formula: C₁₁H₁₄ClNO
• Molecular Weight: 211.69
• Mol File: 97839-99-1.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 312.8°C at 760 mmHg
• Flash Point: 142.9°C
• Appearance: /
• Density: 1.15g/cm³
• Vapor Pressure: 0.000519mmHg at 25°C
• Refractive Index: 1.538
• Storage Temp.: 2-8°C
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: 4-(4-CHLORO-PHENOXY)-PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-CHLORO-PHENOXY)-PIPERIDINE(97839-99-1)
• EPA Substance Registry System: 4-(4-CHLORO-PHENOXY)-PIPERIDINE(97839-99-1)

Safety Data

• Hazardous Substances Data: 97839-99-1(Hazardous Substances Data)

Usage

Uses

It is employed as intermediate for pharmaceutical.

InChI:InChI=1/C11H14ClNO/c12-9-1-3-10(4-2-9)14-11-5-7-13-8-6-11/h1-4,11,13H,5-8H2

Upstream product

• 333954-83-9 tert-butyl 4-(4-chlorophenoxy)piperidine-1-carboxylate 
• 106-48-9 4-chloro-phenol 
• 28231-84-7 4-(4-chlorophenoxy)pyridine 
• 626-61-9 4-Chloropyridine 

Downstream Products

• 496055-22-2 [4-(4-chloro-phenoxy)-piperidin-1-yl]-oxo-acetic acid ethyl ester 
• 1304781-43-8 benzo[d]isoxazol-3-yl-(4-(4-chlorophenoxy)piperidin-1-yl)methanone 
• 1233228-06-2 1-(4-chloro-5-methoxy-2-nitro-phenoxy)-3-[4-(4-chloro-phenoxy)-piperidin-1-yl]-propan-2-ol 
• 1233227-97-8 1-[3-(4-Chloro-5-methoxy-2-nitro-phenoxy)-propyl]-4-(4-chloro-phenoxy)-piperidine 
• 1219625-79-2 1-{2-[4-(4-chlorophenoxy)piperidin-1-yl]-2-oxoethyl}-3,3-diphenylpiperidin-2-one 
• 1174043-28-7 C₂₆H₂₃ClN₄O₃ 
• 210917-87-6 4-(4-chlorophenoxy)piperidine-1-sulfonyl chloride 
• 1088900-88-2 4-(4-chlorophenoxy)-N-(2-methylbut-3-yn-2-yl)piperidine-1-sulfonamide 
• 296765-79-2 {2-[4-(4-Chlorophenoxy)piperidine-1-sulfonyl]phenyl}acetic acid 
• 875211-48-6 5-{2-[4-(4-chloro-phenoxy)-piperidin-1-yl]-2-oxo-ethoxy}-3H-benzooxazol-2-one 

Relevant articles and documents

MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS

The invention provides compounds of formula I or pharmaceutically acceptable salt, solvate or hydrate thereof (I) wherein ring A represents group A-I or A- II (A-I, A-II) A1, A2, A3, A4 represent independently C(R4aa) or N, wherein no more than one of A1, A2, A3, and A4 represents N; A5 represents C(R4b) or N; B1, B2, B3 and B4 represent independently C(R3) or N, wherein no more than two of B1, B2, B3 and B4 represent N; n is 1 or 2; and R1, R2, R3, R4a and R4aa and R4b are as defined in the claims, as well as methods of using the compounds to treat proliferation diseases, in particular cancer.

NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS

The present invention relates to novel morpholine, oxazapane and piperidine derivatives that act as ligands for CC chemokine receptors, such as CCR1. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.

ANTIPARASITIC TERPENE ALKALOIDS

The present invention relates to novel terpene alkaloids and their use as antiparasitic agents. The present invention also relates to an antiparasitic agent which comprises a terpene alkaloid compound of this invention as an effective ingredient in an antiparasitic formulation. More particularly, the present invention relates to derivatives of the terpene alkaloid (1S,2R,4aS,5R,8R,8aR)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(1-methylethenyl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl (2S,3aR,9bR)-6-chloro-9b-hydroxy-5-methyl-1,2,3,3a,5,9b-hexahydropyrrolo[2,3-c][2,1]benzoxazine-2-carboxylate. Pharmaceutical compositions comprising the same are also disclosed.